Related Experiment Video
Updated: May 6, 2026
08:27
Muscle Velocity Recovery Cycles to Examine Muscle Membrane Properties
Published on: February 19, 2020
14.3K
Camptocormia secondary to polymyositis
Revista Brasileira De Reumatologia
|November 13, 2013
Summary
Camptocormia, a spinal flexion disorder, can occur with polymyositis, a rare idiopathic inflammatory myopathy. This case highlights a stable presentation in a long-term polymyositis patient.
Area of Science:
- Neurology
- Rheumatology
- Orthopedics
Background:
- Camptocormia is a postural disorder involving abnormal thoracolumbar spine flexion.
- Idiopathic inflammatory myopathies (IIMs) are rare causes of secondary camptocormia, with only five cases reported.
- Polymyositis is an IIM characterized by symmetric proximal muscle weakness.
Observation:
- A 67-year-old male with an 18-year history of polymyositis presented with camptocormia.
- The patient's camptocormia symptoms were stable and did not progress over time.
- Polymyositis, being a systemic autoimmune disease, can affect paravertebral muscles, leading to camptocormia.
Findings:
- This case report details a rare instance of camptocormia associated with long-standing polymyositis.
- The patient's condition remained stable, suggesting a non-progressive form of myopathy-induced camptocormia.
- Paravertebral muscle involvement in polymyositis can manifest as camptocormia.
Implications:
- This case expands the understanding of potential musculoskeletal manifestations in polymyositis.
- It suggests that camptocormia can be a stable, non-progressive complication of idiopathic inflammatory myopathies.
- Further research may elucidate the specific mechanisms linking polymyositis to camptocormia.
Related Concept Videos
01:25Cardiomyopathy I: Introduction and Classification
828
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
828
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
957
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
957
01:20Myasthenia Gravis: Overview and Treatment
3.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
01:22Myasthenia Gravis ll: Pathophysiology
69
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
69
01:27Myocarditis II: Clinical Features and Diagnostic Tests
496
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
496
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
810
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810